Photodynamic therapy using intravenous δ-aminolaevulinic acid-induced protoporphyrin IX sensitisation in experimental hepatic tumours in rats

British Journal of Cancer

Volumn 74, Issue 10, 1996, Pages 1526-1533

  Svanberg, K ^a,b   Liu, D L ^a,b   Wang, I ^a,b   Andersson Engels, S ^b,c   Stenram, U ^a,b   Svanberg, S ^b,c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Lund University   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Hepatic tumour; Laser Doppler imaging; Laser induced fluorescence; Photodynamic therapy; Photosensitiser; Protoporphyrin IX; aminolaevulinic acid

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ABDOMINAL WALL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR SYSTEM; EXPERIMENTAL NEOPLASM; FLUORESCENCE; LIVER; LIVER TUMOR; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; TUMOR CELL;

EID: 0029982941     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.584     Document Type: Article

References (54)

1. ADSON MA (1986). Liver resection in primary and secondary liver cancer. In Liver Surgery. Bengmark S and Blumgart LH (eds). pp. 63-80. Churchill Livingstone: Edinburgh.
2. ALIAN W, ANDERSSON-ENGELS S, SVANBERG K AND SVANBERG S. (1994). Laser-induced fluorescence studies of meso-tetra(hydroxyphenyl)chlorin in malignant and normal tissue in rats. Br. J. Cancer, 70, 880-885.
3. ANDERSSON T, BERG R, JOHANSSON D, KILLANDER D, SVANBERG K, SVANBERG S AND YANG YUANONG (1992). Photo-dynamic therapy in interplay with fluorescence diagnostics in the treatment of human superficial malignancies. SPIE. 1645, 187-199.
4. ANDERSSON-ENGELS S, ELNER Å, JOHANSSON J, KARLSSON S-E, SALFORD LG, STROMBLAD L-G, SVANBERG K AND SVANBERG S. (1991). Clinical recording of laser-induced fluorescence spectra for evaluation of tumour demarcation feasibility in selected clinical specialities. Lasers Med. Sci., 6, 415-424.
5. ANDERSSON-ENGELS S, ANKERST J, JOHANSSON J, SVANBERG K AND SVANBERG S. (1993). Laser-induced fluorescence in malignant and normal tissue of rats injected with benzoporphyrin derivative. Pholochem. Photobiol., 57, 978-983.
6. ANKERST J, MONTÁN S, SVANBERG K AND SVANBERG S. (1984). Laser-induced fluorescence studies of hematoporphyrin derivative (HPD) in normal and tumour tissue of rats. Appl. Spectroscopy, 38, 890-896.
7. BELLNIER DA AND HENDERSON BW. (1992). Determinants for photodynamic tissue destruction. In Photodynamic Therapy. Henderson BW and Dougherty TJ (eds). pp. 117-127. Marcel Dekker: New York.
8. BEDWELL J, MACROBERT AJ, PHILLIPS D AND BOWN SG. (1992). Fluorescence distribution and photodynamic effect of ALA-induced PPIX in the DMH rat colonie tumour model. Br. J. Cancer, 65, 818-824.
9. BERENBAUM MC, AKANDE SL, BONNETT R, KAUR H, IOANNOU S, WHITE RD AND WINFIELD UJ. (1986). meso-Tetra(hydroxyphenyl) porphyrins, a new class of potent tumour photosensitisers with favourble selectivity. Br. J. Cancer, 54, 717-725.
10. BUGELSKI PJ, PORTER CW AND DOUGHERTY TJ. (1981). Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res., 41, 4606-4612.
11. CARLSSON JR G, GULLBERG B AND HAESTRÖM LO. (1983). Estimation of liver tumour volume using different formulas an experimental study in rats. J. Cancer Res. Clin. Oncol., 105, 20-23.
12. DAILEY HA AND SMITH A. (1984). Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. Biochem. J., 223, 441-445.
13. EVRARD S, APRAHAMIAN M AND MARESCAUX J. (1993). Intraabdominal photodynamic therapy: from theory to feasibility. Br. J. Surg., 80, 298-303.
14. 14C]hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res., 39, 146-151.
15. GRANT WE, HOPPER C, MACROBERT AJ, SPEIGHT PM AND BOWN SG. (1993). Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid. Lancet, 342, 147-148.
16. HAHL J, HAAPIAINEN R, OVASKA J, PUOLAKKAINEN P AND SCHRÖDER T. (1990). Laser-induced hyperthermia in the treatment of liver tumors. Lasers Surg. Med., 10, 319-321.
17. HEDLUND G AND SJÖÜREN HO. (1980). Induction of transplantation immunity to rat colon carcinoma isografts by implantation of intact fetal colon tissue. Int. J. Cancer, 26, 71-73.
18. HENDERSON BW, WALDOW S, MANG TA, POTTER WR, MALONE PB AND DOUGHERTY TJ. (1985). Tumour destruction and kinetics of tumour cell death in two experimental mouse tumours following photodynamic therapy. Cancer Res., 45, 572-576.
19. HOLT S, TULIP J, HAMILTON D, CUMMINS J, FIELDS A AND DICK C. (1985). Experimental laser phototherapy of the Morris 7777 hepatoma in the rat. Hepatology, 5, 175-180
20. JAMIESON CHM, DOLPHIN D AND LEVY J. (1989). Differential uptake of benzoprphyrin derivative (BPD) by leukemic versus normal cells. SPIE Proc., 1065, 152-163.
21. JOHANSSON J, BERG R, SVANBERG K AND SVANBERG S. (1996). Laser-induced studies of normal and malignant tumor tissue of rat following intravenous injection of δ-amino levulinic acid. Lasers Surg. Med. (in press).
22. KAWASAKI S, MAKUUCHI M, KAKAZU T, MIYAGAWA S, TAKAYAMA T, KOSUGE T, SUGIHARA K AND MORIYA Y (1994). Resection for multiple metastatic liver tumor after portal embolization. Surgery, 115, 674-677.
23. KENNEDY JC, POTTIER RH AND PROSS DC. (1990). Photodynamic therapy with endogenous protoporphrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B: Biol., 6, 143-148.
24. KENNEDY JC AND POTTIER RH. (1992). Endogenous protoporphyrin IX. a clinically useful photosensitiser for photodynamic therapy. J. Photochem. Photobiol. B: Biol., 14, 275-292.
25. KESSEL D. (1984). Hematoporphyrin and HPD: photophysics, photochemistry and phototherapy. Photochem. Photobiol., 39, 851-859.
26. LAFRENIERE R AND ROSENBERG SA. (1986). A novel approach to the generation and identification of experimental hepatic metastases in a murine model. J. Natl Cancer Inst., 76, 309-315.
27. LEIBOVICI L, SCHOENFELD NILI, YEHOSHUA HA, MAMET R, RAKOWSKI E, SHINDEL A AND ATSMON A. (1988). Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer. Cancer, 62, 2297-2300.
28. LEVECKIS J, BROWN NJ AND REED MWR. (1995). The effect of aminolacvulinic acid-induced, protoporphyrin IX-mediated photodynamic therapy on the cremaster muscle microcirculation in vivo. Br. J. Cancer, 72, 1113-1119.
29. LIU LX, SVANBERG K, WANG I, STENRAM U, ANDERSSON-ENGELS S AND SVANBERG S. (1993). Liver twin tumours: a new experimental hepatic tumour model in the investigation of various treatment strategies. Med. Sci. Res., 21, 703-706.
30. MALIK Z AND LUGACI H. (1987). Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrin. Br. J. Cancer, 56, 589-595.
31. MOAN J, JOHANNESSEN JV AND CHRISTENSEN T. (1982). Porphyrin-sensitized photoinactivation of human cells in vitro. Am. J. Pathol., 109, 184-192.
32. NISHIWAKI Y, NAKAMURA S AND SAKAGUCHI S. (1989). New method of photosensitizer accumulation for photodynamic therapy in an experimental liver tumour. Lasers Surg. Med., 9, 254-263.
33. PASS HI. (1991). Photodynamic therapy for lung cancer. Chest Surg. Clin. North Am., 1, 135-151.
34. PASS HI. (1993). Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl Cancer Inst., 85, 443-456.
35. PETERSON HI. (1991). Modification of tumour blood flow a review. Int. J. Radiat. Biol., 60, 201-210.
36. PIMSTONE NR, HORNER IJ, SHAYLOR-BILLINGS J AND GANDHI SN. (1982). Hematoporphyrin-augmented phototherapy in experimental liver cancer in the rat. SPIE Proc., 357, 60-67.
37. RAVIKUMAR TS, KANE R, CADY B, JENKINS R, CLOUSEL Y AND STEELE Jr G. (1991). A 5-year study of cryosurgery in the treatment of liver tumours. Arch. Surg., 126, 1520-1524.
38. RICHTER AM, KELLY B, CHOW DJ, LIU J, NEIL TOWERS GH, DOLPHIN D AND LEVY J. (1987). Preliminary studies on a more effective phototoxic agent than hematoporphyrin. J. Natl Cancer Inst., 79, 1327-1332.
39. RINGE B, PICHLMAYR R, WITTEKIND C AND TUSCH G. (1991). Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J. Surg., 15, 270-285.
40. RIS H-B, ALTERMATT HJ, INDERBITZI R, HESS R, NACHBUR B, STEWART JCM, WANG Q, LIM CK, BONNETT R, BERENBAUM MC AND ALTHAUS U. (1991). Photodynamic therapy with chlorines for diffuse malignant mesothelioma: initial clinical results. Br. J. Cancer, 64, 1116-1120.
41. ROBERTS DJH, CAIRNDUFF F, DRIVER I, DIXON B AND BROWN SB. (1994). Tumour vascular shutdown following photodynamic therapy based on polyhaematoporphyrin or 5-aminolevulinic acid. Int. J. Oncol., 5, 763-768.
42. RUBINO GF AND RASETTI L. (1966). Porphyrin metabolism in human neoplastic tissue. Panminerva Med., 8, 290-292.
43. SARDESAI VM, WALDMAN J AND ORTEN JM. (1964). A comparative study of porphyrin biosynethesis in different tissues. Blood, 24, 178-186.
44. SCHOENFELD N, EPSTEIN O, LAHAV M, MAMET R, SHARKLAI M AND ATSMON A. (1988). The heme biosynthetic pathway in lymphocytes of patient with malignant lymphoproliferative disorders. Cancer Lett., 43, 43-48.
45. SELMAN SH, KREIMER-BIRNBAUM M, KLAUNIG JE, GOLDBLATT PJ, KECK RW AND BRITTON SL. (1984). Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. Cancer Res., 44, 1924-1927.
46. STAR WM, MARUNISSEN HPA, BERG-BLOCK AE, VERSTEEG AC, FRANKEN KAP AND REINHOLD HS. (1986). Destruction of rat mammary tumour and normal tissue microcirculation by haematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res., 46, 2532-2540.
47. SVANBERG K, KJELLÉN E, MONTAN S, SJÖHOLM E AND SVANBERG S (1986). Fluorescence studies of hematoporphyrin derivative in normal and malignant rat tissue. Cancer Res., 46, 3803-3808.
48. SVANBERG K, ANDERSSON T, KILLANDER D, STENRAM U, ANDERSSON-ENGELS S, BERG R, JOHANSSON J AND SVANBERG S. (1994). Photodynamic therapy of non-melanoma malignant tumours of the skin topical δ-amino levulinic acid (ALA) sensitisation and laser irradiation. Br. J. Dermatol., 130, 743-751.
49. VAN DER VEEN N, VAN LEENGOED HLLM AND STAR WM. (1994). In vivo fluorescence kinetics and photodynamic therapy using 5-aminolevulinic acid-induced porphyrin: increased damage after multiple irradiations. Br. J. Cancer., 70, 867-872.
50. VAN HILLEGERSBERG R, MARIJINISSEN JPA, KORT WJ, ZONDERVAN PE, TERPSTRA OT AND STAR WM. (1992a). Interstitial photodynamic therapy in a rat liver metastasis model. Br. J. Cancer, 66, 1005-1014.
51. VAN HILLEGERSBERG R, VAN DEN BERG JWO, KORT WJ, TERPSTRA OT AND WILSON JH. (1992b). Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology, 103, 647-651.
52. WANG I, ANDERSSON-ENGELS S, NILSSON GE, WÅRDELL K AND SVANBERG K. (1996). Superficial bloodflow following photodynamic therapy of malignant skin tumours measured by laser Doppler perfusion imaging. Br. J. Dermatol., (in press).
53. WARLOE T, PENG Q, HEYERDAHL H, MOAN J, STEEN HB AND GIERCKSKY K-E. (1994). Photodynamic therapy with 5-aminolevulinic acid induced porphyrins and DMSO EDTA for basal cell carcinoma. SPIE, 2371, 226-235.
54. WARDELL K, JAKOBSSON A AND NILSSON GE. (1993). Laser Doppler perfusion imaging by dynamic light scattering. IEEE Trans. Biomed. Eng., 40, 309-316.